Promotion Wiebke Winkens Abgabeversion 2 - RWTH

Literaturverzeichnis
Vainio S, Heikkilä M, Kispert A, Chin N, McMahon AP: Female development in
mammals is regulated by Wnt-4 signalling. Nature. (1999) Feb 4;397(6718):405-9
Varley JM, Swallow JE, Brammar WJ, Whittaker JL, Walker RA: Alterations to either
c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-
term prognosis. Oncogene. 1987;1(4):423-30.
Veeck J, Niederacher D, An H, Klopocki E, Wiesmann F, Betz B, Galm O, Camara O,
Dürst M, Kristiansen G, Huszka C, Knüchel R, Dahl E: Aberrant methylation of the
Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis.
Oncogene. (2006) Jun 8;25(24):3479-88. Epub 2006 Jan 30
Vogelstein B, Kinzler KW: Cancer genes and the pathways they control. Nat Med.
(2004) Aug;10(8):789-99.
Weber-Hall SJ, Phippard DJ, Niemeyer CC, Dale TC: Developmental and hormonal
regulation of Wnt gene expression in the mouse mammary gland. Differentiation.
(1994) Sep;57(3):205-14
Weinberg RA: Oncogenes, antioncogenes, and the molecular bases of multistep
carcinogenesis. Cancer Res. (1989) Jul 15;49(14):3713-21.
Wittekind C, Meyer H J: TNM, Klassifikation maligner Tumoren, 7. Auflage (2010),
Wiley-Blackwell-Verlag
Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S,
Tran T, Averill D, et al.: Localization of a breast cancer susceptibility gene, BRCA2, to
chromosome 13q12-13. Science. (1994) Sep 30;265(5181):2088-90.
Yang F, Zeng Q, Yu G, Li S, Wang CY: Wnt/beta-catenin signaling inhibits death
receptor-mediated apoptosis and promotes invasive growth of HNSCC. Cell Signal.
(2006) May;18(5):679-87
Zhang XL, Peng CJ, Peng J, Jiang LY, Ning XM, Zheng JH: Prognostic role of Wnt7a
expression in ovarian carcinoma patients. Neoplasma. (2010) ;57(6):545-51
69